Tao Synergies Inc. (TAOX) fundamentals score
From August 23, 2013 to December 6, 2020, Synaptogenix, Inc. (formerly known as Neurotrope Bioscience, Inc.) was a wholly owned subsidiary of Neurotrope, Inc. (“Neurotrope”). Neurotrope’s operations were solely those of Synaptogenix. On May 17, 2020, Neurotrope announced plans for the complete legal and structural separation of Synaptogenix from Neurotrope (the “Spin-Off”).
Credit Services · Financial Services · Listed on NASDAQ
Overall: 3.4 out of 10, Unhealthy fundamentals
- Growth: 3.5/10
- Profitability: 1.0/10
- Financial health: 6.0/10
- Earnings quality: 5.5/10
- Valuation: 1.5/10
Scores are calculated from Tao Synergies Inc.’s SEC filings, using the 12 months through 2026-06. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Financial Services stocks
- Slide Insurance Holdings, Inc. (SLDE): 9.7/10
- Cincinnati Financial Corporation (CINF): 9.3/10
- Brookfield Asset Management Ltd. (BAM): 9.2/10
- Affiliated Managers Group, Inc. (MGR): 9.1/10
- Affiliated Managers Group, Inc. (MGRB): 9.1/10
- Affiliated Managers Group, Inc. (MGRD): 9.1/10
- Affiliated Managers Group, Inc. (MGRE): 9.1/10
- Allstate Corp. (ALL): 9.0/10